Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 47:98-107, doi:10.1016/j.jacc.2005.08.049 (Published online 12 December 2005).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2005.08.049v1
47/1/98    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (38)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daubert, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daubert, J. P.

CLINICAL RESEARCH: HEART RHYTHM DISORDER

Predictive Value of Ventricular Arrhythmia Inducibility for Subsequent Ventricular Tachycardia or Ventricular Fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Patients

James P. Daubert, MD*,*, Wojciech Zareba, MD, PhD*, W. Jackson Hall, PhD{dagger}, Claudio Schuger, MD{ddagger}, Andrew Corsello, MD§, Angel R. Leon, MD||, Mark L. Andrews, MS*, Scott McNitt, MS*, David T. Huang, MD*, Arthur J. Moss, MD* for the MADIT II Study Investigators

* Cardiology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, New York
{dagger} Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York
{ddagger} Department of Medicine, Henry Ford Health System, Detroit, Michigan
§ Maine Medical Center, Portland, Maine
|| Department of Medicine, Emory University/Crawford Long Hospital, Atlanta, Georgia

Manuscript received January 8, 2005; revised manuscript received April 13, 2005, accepted August 1, 2005.

* Reprint requests and correspondence: Dr. James P. Daubert, Box 679-Cardiology, University of Rochester Medical Center, Rochester, New York 14642. (Email: James_Daubert{at}URMC.Rochester.edu).

OBJECTIVES: We correlated electrophysiologic inducibility with spontaneous ventricular tachycardia (VT) or ventricular fibrillation (VF) in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II.

BACKGROUND: In the MADIT II study, 593 (82%) of 720 implantable cardioverter-defibrillator (ICD) randomized patients underwent electrophysiologic testing. Patients received an ICD whether they were inducible or not.

METHODS: A "standard" inducibility definition included sustained monomorphic or polymorphic VT induced with three or fewer extrastimuli or VF induced with two or fewer extrastimuli. We compared a narrow inducibility definition (only monomorphic VT) and a broad definition (standard definition plus VF with three extrastimuli). We used ICD-stored electrograms to categorize spontaneous VT or VF.

RESULTS: Inducible patients (standard definition) had a greater likelihood of experiencing ICD therapy for VT than noninducible patients (p = 0.023). Unexpectedly, ICD therapy for spontaneous VF was less common (p = 0.021) in inducible patients than in noninducible patients. The two-year Kaplan-Meier event rate for VT or VF was 29.4% for inducible patients and 25.5% for noninducible patients. Standard inducibility did not predict the combined end point of VT or VF (p = 0.280, by log-rank analysis). The narrow inducibility definition outperformed the standard definition, whereas the broad definition appeared inferior to the standard definition.

CONCLUSIONS: In the MADIT II study patients, inducibility was associated with an increased likelihood of VT. Noninducible MADIT II study subjects using this electrophysiologic protocol had a considerable VT event rate and a higher VF event rate than inducible patients. Induction of polymorphic VT or VF, even with double extrastimuli, appears less relevant than induction of monomorphic VT.

Abbreviations and Acronyms
  ATP = anti-tachycardia pacing
  EP = electrophysiologic
  HR = hazard ratio
  ICD = implantable cardioverter-defibrillator
  MADIT = Multicenter Automatic Defibrillator Implantation Trial
  MI = myocardial infarction
  RV = right ventricular
  VF = ventricular fibrillation
  VT = ventricular tachycardia




This article has been cited by other articles:


Home page
EuropaceHome page
E. M. Kanoupakis, E. G. Manios, and P. E. Vardas
Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers
Europace, November 1, 2009; 11(11): 1434 - 1439.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Tung and C. D. Swerdlow
Refining Patient Selection for Primary Prevention Implantable Cardioverter-Defibrillator Therapy: Reeling in a Net Cast Too Widely
Circulation, September 8, 2009; 120(10): 825 - 827.
[Full Text] [PDF]


Home page
EuropaceHome page
J. Marti-Almor, M. Cladellas, V. Bazan, C. Altaba, M. Guijo, J. Delclos, and J. Bruguera-Cortada
Long-term mortality predictors in patients with chronic bifascicular block
Europace, September 1, 2009; 11(9): 1201 - 1207.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. P. Daubert
Why Are (Only) Some Infarcted Hearts Arrhythmogenic?
J. Am. Coll. Cardiol., July 7, 2009; 54(2): 174 - 175.
[Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
S. D. Roes, C. J. W. Borleffs, R. J. van der Geest, J. J.M. Westenberg, N. A. Marsan, T. A.M. Kaandorp, J. H.C. Reiber, K. Zeppenfeld, H. J. Lamb, A. de Roos, et al.
Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator
Circ Cardiovasc Imaging, May 1, 2009; 2(3): 183 - 190.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P.A. Scott, S. Gorman, N.P. Andrews, P.R. Roberts, and P.R. Kalra
Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006)
Europace, April 1, 2008; 10(4): 453 - 457.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Goldenberg, A. K. Vyas, W. J. Hall, A. J. Moss, H. Wang, H. He, W. Zareba, S. McNitt, M. L. Andrews, and for the MADIT-II Investigators
Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction
J. Am. Coll. Cardiol., January 22, 2008; 51(3): 288 - 296.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G. M. De Ferrari, R. Rordorf, F. Frattini, B. Petracci, P. De Filippo, and M. Landolina
Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator
Europace, December 1, 2007; 9(12): 1151 - 1157.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
R. Worck, J. Haarbo, and P. E. B. Thomsen
Electrophysiological study and 'slow' ventricular tachycardia predict appropriate therapy: results from a single-centre implantable cardiac defibrillator follow-up
Europace, November 1, 2007; 9(11): 1048 - 1053.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Passman and A. Kadish
Sudden Death Prevention With Implantable Devices
Circulation, July 31, 2007; 116(5): 561 - 571.
[Full Text] [PDF]


Home page
HeartHome page
Y. G. Yap, T. Duong, J M. Bland, M. Malik, C. Torp-Pedersen, L. Kober, M. M Gallagher, and A J. Camm
Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction
Heart, July 1, 2007; 93(7): 832 - 836.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. J. Zimetbaum
A 59-Year-Old Man Considering Implantation of a Cardiac Defibrillator
JAMA, May 2, 2007; 297(17): 1909 - 1916.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Goldenberg, A. J. Moss, S. McNitt, W. Zareba, W. J. Hall, M. L. Andrews, and for the MADIT-II Investigators
Inverse Relationship of Blood Pressure Levels to Sudden Cardiac Mortality and Benefit of the Implantable Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction
J. Am. Coll. Cardiol., April 3, 2007; 49(13): 1427 - 1433.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Schoenfeld
Contemporary Pacemaker and Defibrillator Device Therapy: Challenges Confronting the General Cardiologist
Circulation, February 6, 2007; 115(5): 638 - 653.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. M. Narayan
T-Wave Alternans and Human Ventricular Arrhythmias: What Is the Link?
J. Am. Coll. Cardiol., January 23, 2007; 49(3): 347 - 349.
[Full Text] [PDF]


Home page
CirculationHome page
F. J. Klocke, E. Wu, and D. C. Lee
"Shades of Gray" in Cardiac Magnetic Resonance Images of Infarcted Myocardium: Can They Tell Us What We'd Like Them to?
Circulation, July 4, 2006; 114(1): 8 - 10.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Vanishing Role of EP Testing in Determining Arrhythmia Risk
Journal Watch Cardiology, March 2, 2006; 2006(302): 2 - 2.
[Full Text]


Home page
J Am Coll CardiolHome page
R. J. Myerburg and A. Castellanos
Clinical Research Designs and Implantable Defibrillator Indications: Spend in the Beginning or Pay at the End
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 108 - 111.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement